The abuse risk of new non-benzodiazepine hypnotics such as zolpidem has bee
n discussed in a number of recent publications. We performed a Medline anal
ysis which showed that, to date, 15 cases of abuse or dependence have been
published. In 6 patients, the abuse was secondary to other forms of abuse O
F dependence. Other data from medical statistics and pharmacoepidemiologica
l studies suggest the abuse potential of zolpidem to be much lower than tha
t of other hypnotics. We conclude that zolpidem is a relatively safe drug c
ompared to conventional hypnotics. Patients with other substance abuse hist
ories may be considered as risk patients for later abuse of zolpidem.